Regulation of N-Myc downstream regulated gene 2 by bile acids

•Bile acid CDCA induces tumor suppressor NDRG2 expression in hepatocytes.•Induction of NDRG2 by bile acids requires FXR expression.•An intronic FXR-response element was identified in human and murine genes.•FXR activation increases NDRG2 mRNA and protein levels in kidney.•We provide knowledge toward...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications Vol. 434; no. 1; pp. 102 - 109
Main Authors: Langhi, Cédric, Pedraz-Cuesta, Elena, Donate, Yolanda, Marrero, Pedro F., Haro, Diego, Rodríguez, Joan C.
Format: Journal Article
Language:English
Published: United States Elsevier Inc 26-04-2013
Elsevier B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Bile acid CDCA induces tumor suppressor NDRG2 expression in hepatocytes.•Induction of NDRG2 by bile acids requires FXR expression.•An intronic FXR-response element was identified in human and murine genes.•FXR activation increases NDRG2 mRNA and protein levels in kidney.•We provide knowledge toward the understanding of NDRG2 physiological function. Here we report that bile acid chenodeoxycholic acid (CDCA) and synthetic farnesoid X receptor (FXR) agonist GW4064 robustly induced tumor suppressor N-Myc downstream regulated gene 2 (NDRG2) expression in human hepatoma cells and primary hepatocytes. Knockdown of FXR abolished the induction by CDCA, whereas overexpression of a constitutively active form of FXR increased NDRG2 expression. A FXR-response element was identified within intronic regions of human and murine genes. Moreover, mice given GW4064 exhibit an increase of Ndrg2 expression in liver and kidney, where both NDRG2 and FXR are enriched. The identification of NDRG2 as a bile acid regulated gene may provide novel knowledge toward the understanding of NDRG2 physiological function and the link between metabolism and cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2013.03.058